eli lilly phase 3 trial retatrutide Lilly's triple agonist hits 28.3% mean weight loss in TRIUMPH-1 3, blowing past tirzepatide benchmarks & rewriting obesity math for payers, PBMs & the Novo Duopoly A Study of Retatrutide (LY3437943)
Pay in 4 interest-free payments of $6.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
















:max_bytes(150000):strip_icc()/Health-GettyImages-1675158771-70640c9fdf1b41078975cfc3fd538a6b.jpg)









